A new version of the coved vaccine, targeting omacron ariant b a five, is expected to become available in the next few weeks. The fda is expected to make a determination on the drug prior to the completion of human trials. There's a concern that with covid, repeat boosters may actually weaken the immune system. Johns hopkins and doctor marty mc cary discuss what we know so far about the new vaccine.